Therapy News and Research

RSS

Detailed atlas of the mammalian primary motor cortex will provide a springboard for future research

The NIH Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative Cell Census Network (BICCN) has unveiled an atlas of cell types and an anatomical neuronal wiring diagram for the mammalian primary motor cortex, derived from detailed studies of mice, monkeys, and humans.

6 Oct 2021

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in the brain.

6 Oct 2021

New understanding of cellular defects related to Cystic Fibrosis may pave the way for treatments

A team in the College of Medicine led by Drs. Juan Ianowski (PhD) and Julian Tam (MD) found that sodium transport is abnormal in lungs with CF.

6 Oct 2021

Enisamium shows potential as antiviral therapy for COVID-19

Researchers studied the effect of enisamium on the growth and proliferation of Caco-2 and normal human bronchial epithelial cells.

6 Oct 2021

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Researchers at the Centre for Genomic Regulation and Pulmobiotics S.L have created the first 'living medicine' to treat antibiotic-resistant bacteria growing on the surfaces of medical implants. The researchers created the treatment by removing a common bacteria's ability to cause disease and repurposing it to attack harmful microbes instead.

6 Oct 2021

Study shows strong protective effect of IgG3 antibodies in SARS-CoV-2 infection

Researchers published a study on the expression and functional analyses of a neutralizing mAb with identical variable domains but different constant HCs, representing IgG1-4.

6 Oct 2021

Menopausal Hormone Therapy and Dementia

News-Medical speaks to Dr. Yana Vinogradova about her latest research into menopausal hormone therapy (MHT) and its unassociated risk to dementia.

6 Oct 2021

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.

6 Oct 2021

Researchers identify mechanism that can lead to deafness in rare Norrie disease

A team of Mass Eye and Ear Scientists led by Albert Edge, PhD, working with research fellow Yushi Hayashi, MD, PhD, has identified the mechanism that can lead to deafness in the rare syndrome, Norrie disease.

5 Oct 2021

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

New mathematical modeling technique can accurately predict tumor response to chemotherapy

A public/private collaboration led by researchers at The University of Texas at Austin has resulted in a new mathematical modeling technique that can accurately predict the response of tumors in breast cancer patients to treatments such as chemotherapy soon after treatment initiation.

5 Oct 2021

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.

5 Oct 2021

Binghamton professor collaborates on $3.1 million grant to help Black and Latinx youth living with HIV

A new $3.1-million, four-year grant co-led by faculty at Binghamton University, State University of New York could help African American and Latinx youth living with HIV.

5 Oct 2021

NYU Langone Health broadens access to high-quality primary and specialty care

NYU Langone Health continues to broaden access to high-quality primary and specialty care with recent expansions in Long Island, Queens, Manhattan, and Brooklyn.

5 Oct 2021

Anti-CD20 therapy patients can develop immune responses after SARS-CoV-2 vaccination

A new systematic review and meta-analysis focused on the humoral and cell-mediated immune responses after COVID-19 vaccination in patients undergoing anti-CD20 antibodies treatment.

5 Oct 2021

Managing metabolic disease through time-restricted eating

In this interview, News-Medical speaks to Dr. Satchin Panda about his latest research into time-restricted eating and how it can be used to manage metabolic diseases.

5 Oct 2021

The pandemic forced my transgender wife to fight our insurer over hormones

For the past eight years, my wife, Ky Hamilton, has undergone gender-affirming hormone therapy. As a transgender woman, she injects Depo-Estradiol liquid estrogen into her thigh once a week.

5 Oct 2021

CAR-T cells require an abundance of antigens to efficiently kill solid tumors

Immunotherapy, which harnesses the power of the body's immune system to fight disease, is gaining huge traction in treating cancer.

5 Oct 2021

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Your saliva may be able to tell you if you’ve developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, suggests a new medRxiv* preprint study. In immunocompromised groups, salivary Immunoglobulin G (IgG) antibody levels were associated with IgG titers in blood serum 3 to 4 weeks after mRNA vaccination.

5 Oct 2021

MR study finds no causal link between age at menarche or age at menopause and Alzheimer's risk

Aging-US published "The role of age at menarche and age at menopause in Alzheimer's disease: evidence from a bidirectional mendelian randomization study" which reported that the association between endogenous estrogen exposure and Alzheimer's disease remains inconclusive in previous observational studies, and few Mendelian randomization studies have focused on their causality thus far.

5 Oct 2021

Therapy News and Research

Detailed atlas of the mammalian primary motor cortex will provide a springboard for future research

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

New understanding of cellular defects related to Cystic Fibrosis may pave the way for treatments

Enisamium shows potential as antiviral therapy for COVID-19

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Study shows strong protective effect of IgG3 antibodies in SARS-CoV-2 infection

Menopausal Hormone Therapy and Dementia

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

Researchers identify mechanism that can lead to deafness in rare Norrie disease

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

New mathematical modeling technique can accurately predict tumor response to chemotherapy

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

Binghamton professor collaborates on $3.1 million grant to help Black and Latinx youth living with HIV

NYU Langone Health broadens access to high-quality primary and specialty care

Anti-CD20 therapy patients can develop immune responses after SARS-CoV-2 vaccination

Managing metabolic disease through time-restricted eating

The pandemic forced my transgender wife to fight our insurer over hormones

CAR-T cells require an abundance of antigens to efficiently kill solid tumors

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

MR study finds no causal link between age at menarche or age at menopause and Alzheimer's risk

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News